, Tracking Stock Market Picks
Enter Symbol:
Spectrum Pharmaceuticals, Inc. (SPPI) [hlAlert]

down 22.78 %

Spectrum Pharmaceuticals, Inc. (SPPI) rated Buy with price target $20.50 by MLV Capital

Posted on: Monday,  May 2, 2011  2:25 PM ET by MLV Capital

MLV Capital rated Buy Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) on 05/02/2011, when the stock price was $9.70. Since
then, Spectrum Pharmaceuticals, Inc. has lost 22.78% as of 12/04/2015's recent price of $7.49.
If you would have followed this MLV Capital's recommendation on SPPI, you would have lost 22.78% of your investment in 1677 days.

Spectrum Pharmaceuticals, Inc. ( Spectrum) is a commercial stage biopharmaceutical company, engaged in developing and commercializing therapies with a focus primarily in the areas of hematology-oncology and urology. The Company?s product is apaziquone (formerly EOquin), which is in two Phase 3 clinical trials for non-muscle invasive bladder cancer under a collaboration with Allergan Inc. Another drug, ozarelix is in a Phase 2 clinical trial for benign prostatic hypertrophy (BPH). On December 15, 2008, Spectrum and Cell Therapeutics, Inc. (CTI) partnered to form a joint venture, RIT Oncology, LLC (RIT), to develop Zevalin ([90Y]-ibritumomab tiuxetan) in the United States. Its subsidiaries include OncoRx Pharma Private Limited, Spectrum Pharmaceuticals GmbH, RIT Oncology, LLC and Spectrum Pharma Canada. During the year ended December 31, 2008, the Company dissolved NeoJB LLC.

MLV Capital is a boutique investment bank and institutional broker-dealer focused on providing independent financial advice and unique capital markets expertise to corporate and institutional clients in capital intensive industries such as metals and mining, life sciences, energy and real estate. With a focus on raising money efficiently for clients, MLV has rapidly become a leader in the At-the-Market(ATM) transaction market.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/2/2011 2:25 PM Buy
9.70 20.50
as of 12/30/2011
1 Week down  -0.94 %
1 Month up  5.63 %
3 Months up  91.74 %
1 YTD up  50.82 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy